4Pardanani A, Ketterling RP, Brockman SR,et al. CHIC2 de- letion,a surrogate for FIP1L1-PDGFRA fusion, occurs in sys temic mastocytosis associated with cosinophilia and predicts response to imatinih mesylate therapy. Blood, 2003:102(9): 3093-3096.
5Karnak D, kayacan O, Beder S, et al. Hypereosinophilic syn drome with pulmonary and cardiac involvement in a patient with asthma. CMAJ ,2003,168(2) : 172-175.
6Carroll M,Ohno-Jones S,Tanuira S,et al. CGP57148, a tyro sine kinase inhibitor, inhibits the growth of cells, expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. Blood, 1997,90(12) :4947-4952.
7Cools J, Deangelo DJ,Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med,2003,348(13) : 1201-1214.
8Kemmler N,Peitsch wk ,Glorer E ,et al, Hypereosinophilic dermatitis[J]. An overlooked diagnosis Hautarzt,2005,56:1060.
9王侠生.杨国亮皮肤病学[M].上海:上海科学技术文献出版社,1996.888.
10Odom RB ,James WP, Berger TG.Andrews ' Disease of the skin[M].9thed. Beijing:scienee press ,2001,940.
